For in vitro diagnostic use. Others LSD IVD LSD CPS_000189 ONLINE DAT Lysergic Acid Diethylamide 20 763 284 122 20763284122 LSD, 200T, cobas c 501/502, Integra LSD 04015630993505 Reagents, kits 2055732122 200 tests COBAS INTEGRA 400 Plus, cobas c 501/502 true 0020763284122c501 LSD Lysergic Acid Diethylamide en 6 FF0000000490390E FF000000002FF20E 20763284122 309 cobas c 501 2324 cobas c 502 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use Lysergic acid diethylamide (LSD) assay is an in vitro diagnostic test for the qualitative detection of LSD and its metabolites in human urine on Roche/Hitachi cobas c systems at a cutoff concentration of 0.5 ng/mL. The LSD assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography or Liquid Chromatography coupled with Mass Spectrometry or Tandem Mass Spectrometry (GC‑MS, GC‑MS/MS, LC‑MS or LC‑MS/MS) is the preferred confirmatory method.LREFReuschel SA, Eades D, Foltz RL. Recent advances in chromatographic and mass spectrometric methods for determination of LSD and its metabolites in physiological specimens. J Chromatogr B Biomed Sci Appl 1999;733(1-2):145-159.,LREFPoch GK, Klette KL, Hallare DA, et al. Detection of metabolites of lysergic acid diethylamide (LSD) in human urine specimens: 2-oxo-3-hydroxy-LSD, a prevalent metabolite of LSD. J Chromatogr B Biomed Sci Appl 1999;724(1):23-33.Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. en 0020763284122COIN LSD ONLINE DAT Lysergic Acid Diethylamide en 7 FF000000037A050E FF0000000186CE0E 20763284122 302 COBAS INTEGRA 400 plus Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useLysergic acid diethylamide (LSD) assay is an in vitro diagnostic test for the qualitative detection of LSD and its metabolites in human urine at a cutoff concentration of 0.5 ng/mL on COBAS INTEGRA systems.The LSD assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result.Gas Chromatography or Liquid Chromatography coupled with Mass Spectrometry or Tandem Mass Spectrometry (GC/MS, GC/MS/MS, LC/MS or LC/MS/MS) is the preferred confirmatory method.LREFReuschel SA, Eades D, Foltz RL. Recent advances in chromatographic and mass spectrometric methods for determination of LSD and its metabolites in physiological specimens. J Chromatogr B Biomed Sci Appl 1999;733(1-2):145-159.,LREFPoch GK, Klette KL, Hallare DA, et al. Detection of metabolites of lysergic acid diethylamide (LSD) in human urine specimens: 2-oxo-3-hydroxy-LSD, a prevalent metabolite of LSD. J Chromatogr B Biomed Sci Appl 1999;724(1):23-33.Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. en

User profile

Select your user profile

LSD

Overview

Ordering information

Technical documents

Compatible products

Related products

Contact us